SEQanswers

Go Back   SEQanswers > Sequencing Technologies/Companies > The Pipeline



Reply
 
Thread Tools
Old 01-16-2012, 06:44 PM   #1
BBoy
Member
 
Location: Pacific Northwest

Join Date: Oct 2010
Posts: 52
Default Genia

http://www.genomeweb.com/sequencing/...-platform-diff

There are not very many details on Genia's website, but what little is there reads like a carbon copy of Oxford's stuff.

So how does this not infringe on everything Oxford is doing?
BBoy is offline   Reply With Quote
Old 01-17-2012, 11:45 PM   #2
jcosta
Junior Member
 
Location: Portugal

Join Date: May 2011
Posts: 4
Default

Donīt know the answer. Only that Life technologies has put alot of money on it!
It is under my radar!
jcosta is offline   Reply With Quote
Old 01-18-2012, 12:56 AM   #3
TonyBrooks
Senior Member
 
Location: London

Join Date: Jun 2009
Posts: 298
Default

I smell a patent war!
TonyBrooks is offline   Reply With Quote
Old 02-09-2012, 11:52 AM   #4
GW_OK
Senior Member
 
Location: Oklahoma

Join Date: Sep 2009
Posts: 383
Default

Interesting interview with their CEO here.

Sounds very, very, very much like ONT. Beta's out at the end of the year, commerical in 2013.
Now, one of the most interesting things is that he's quoting price ranges. Sub-$100 disposable chips and sub-$1k chip readers (about 9:30 in the vid and again at 14:30).
GW_OK is offline   Reply With Quote
Old 02-09-2012, 12:23 PM   #5
ETHANol
Senior Member
 
Location: Western Australia

Join Date: Feb 2010
Posts: 310
Default

He seems to think a lipid bilayer is a cell wall.
__________________
--------------
Ethan
ETHANol is offline   Reply With Quote
Old 02-10-2012, 02:31 PM   #6
scbaker
Shawn Baker
 
Location: San Diego

Join Date: Aug 2008
Posts: 84
Default

I can't comment on the IP issues (there seems to be so much nanopore IP out there, I don't know how they all keep it straight), but what Genia claims to have over other nanopore companies is their expertise in using analog-to-digital sensors directly on integrated circuits. They say it gives them control over the creation of lipid bilayers, the addition of the protein nanopore, and precise control over the movement of the DNA molecules (back and forth through the pore for multiple reads). They also claim to be able to ramp up to 1M sensors (each with an individual pore) on a 1cm X 1cm chip.

I love what ONT is demonstrating with how their instruments can operate in tandem, but it isn't clear how many independent sensors/pores they'll have per well. Does anyone know?

I've placed what I know about Genia and ONT on BlueSEQ's knowledgebank (along with a dozen other emerging NGS technologies): http://blueseq.com/knowledgebank/emerging-technologies/
scbaker is offline   Reply With Quote
Old 02-15-2012, 05:50 AM   #7
Elcannibal
Member
 
Location: Alaska

Join Date: Jan 2012
Posts: 49
Default

I'm still waiting for Starlight...
Elcannibal is offline   Reply With Quote
Old 02-15-2012, 06:40 AM   #8
scbaker
Shawn Baker
 
Location: San Diego

Join Date: Aug 2008
Posts: 84
Default

Quote:
Originally Posted by Elcannibal View Post
I'm still waiting for Starlight...
Yeah, I don't think I'd hold my breath on that one...
scbaker is offline   Reply With Quote
Old 02-15-2012, 11:21 PM   #9
BBoy
Member
 
Location: Pacific Northwest

Join Date: Oct 2010
Posts: 52
Default

Quote:
Originally Posted by scbaker View Post
I love what ONT is demonstrating with how their instruments can operate in tandem, but it isn't clear how many independent sensors/pores they'll have per well. Does anyone know?
They are presenting tomorrow/today I think, we shall see. My prediction is "not very many". Hope I am wrong.
BBoy is offline   Reply With Quote
Old 08-07-2012, 12:29 AM   #10
Biotech Rockstar
CSO, QuantuMDx
 
Location: Newcastle - Singapore - Cape Town - USA

Join Date: Jan 2011
Posts: 6
Default

Quote:
Originally Posted by scbaker View Post
I can't comment on the IP issues (there seems to be so much nanopore IP out there, I don't know how they all keep it straight), but what Genia claims to have over other nanopore companies is their expertise in using analog-to-digital sensors directly on integrated circuits. They say it gives them control over the creation of lipid bilayers, the addition of the protein nanopore, and precise control over the movement of the DNA molecules (back and forth through the pore for multiple reads). They also claim to be able to ramp up to 1M sensors (each with an individual pore) on a 1cm X 1cm chip.

I love what ONT is demonstrating with how their instruments can operate in tandem, but it isn't clear how many independent sensors/pores they'll have per well. Does anyone know?

I've placed what I know about Genia and ONT on BlueSEQ's knowledgebank (along with a dozen other emerging NGS technologies): http://blueseq.com/knowledgebank/emerging-technologies/
No QuantuMDx in your BlueSEQ's knowledgebank?
Biotech Rockstar is offline   Reply With Quote
Old 08-07-2012, 09:30 AM   #11
scbaker
Shawn Baker
 
Location: San Diego

Join Date: Aug 2008
Posts: 84
Default

Quote:
Originally Posted by Biotech Rockstar View Post
No QuantuMDx in your BlueSEQ's knowledgebank?
Not yet, but they should be. I would love to hear more details about how the Q-SEQ device will work. Feel free to contact me directly.
scbaker is offline   Reply With Quote
Old 02-21-2013, 10:07 PM   #12
MrGuy
Member
 
Location: earth

Join Date: Mar 2009
Posts: 68
Default

Quote:
Originally Posted by scbaker View Post
Yeah, I don't think I'd hold my breath on that one...
Some little bird told me starlight is alive.
MrGuy is offline   Reply With Quote
Old 02-22-2013, 04:26 PM   #13
krobison
Senior Member
 
Location: Boston area

Join Date: Nov 2007
Posts: 747
Default

Quote:
Originally Posted by scbaker View Post
Yeah, I don't think I'd hold my breath on that one...
A group at the Salk presented data at AGBT13 using modified Starlight (no quantum dots).
krobison is offline   Reply With Quote
Old 02-22-2013, 04:28 PM   #14
scbaker
Shawn Baker
 
Location: San Diego

Join Date: Aug 2008
Posts: 84
Default

Quote:
Originally Posted by krobison View Post
A group at the Salk presented data at AGBT13 using modified Starlight (no quantum dots).
Very interesting. Do you know if they've purchased the IP from $LIFE or if they have any commercialization plans?
scbaker is offline   Reply With Quote
Old 06-02-2014, 09:56 AM   #15
AllSeq
Registered Vendor
 
Location: San Diego, CA

Join Date: Oct 2013
Posts: 138
Default Roche gets back in the NGS game with purchase of Genia

Quote:
Originally Posted by BBoy View Post
http://www.genomeweb.com/sequencing/...-platform-diff

There are not very many details on Genia's website, but what little is there reads like a carbon copy of Oxford's stuff.

So how does this not infringe on everything Oxford is doing?
After effectively exiting the NGS market in 2013, Roche is making moves to get back into it with their acquisition of Genia for up to $350M ($125 up front and $225 in potential future payments). Read more on our blog.
__________________
AllSeq - The Sequencing Marketplace
[email protected]
www.AllSeq.com
AllSeq is offline   Reply With Quote
Old 06-02-2014, 06:47 PM   #16
BBoy
Member
 
Location: Pacific Northwest

Join Date: Oct 2010
Posts: 52
Default

Quote:
Originally Posted by AllSeq View Post
After effectively exiting the NGS market in 2013, Roche is making moves to get back into it with their acquisition of Genia for up to $350M ($125 up front and $225 in potential future payments). Read more on our blog.
Brilliant move or sign of desperation on the part of Roche? After sending $60M+ down the drain with IBM they are now back to the big dance, now with (apparently) murky IP situation. ONT has licensed so much IP on the biochemistry side that it is not clear (to me) how Genia works around that. Judging from the patents that are now published, the sensors themselves are interesting but not terribly unique. The guys know their analog design (duh), but without biochemistry they will go nowhere. Maybe this is what Roche is banking on - take the platform and add their own biochemistry.
BBoy is offline   Reply With Quote
Old 06-03-2014, 08:48 AM   #17
AllSeq
Registered Vendor
 
Location: San Diego, CA

Join Date: Oct 2013
Posts: 138
Default

Quote:
Originally Posted by BBoy View Post
The guys know their analog design (duh), but without biochemistry they will go nowhere. Maybe this is what Roche is banking on - take the platform and add their own biochemistry.
Genia seems to be claiming two advantages:
1) Precise control over the nanopore assembly process, allowing for 'better than Poisson' distribution

2) NanoTag biochemistry (being co-developed with Columbia and Harvard)

Do you not think this biochemistry confers an advantage (or are you saying they don't really 'own' it due to the murky nanopore IP situation)?
__________________
AllSeq - The Sequencing Marketplace
[email protected]
www.AllSeq.com
AllSeq is offline   Reply With Quote
Old 06-03-2014, 07:04 PM   #18
BBoy
Member
 
Location: Pacific Northwest

Join Date: Oct 2010
Posts: 52
Default

Quote:
Originally Posted by AllSeq View Post
Do you not think this biochemistry confers an advantage (or are you saying they don't really 'own' it due to the murky nanopore IP situation)?
Their hardware, as much as can be judged from their patents and public presentations is elegant. Murky biochem IP is indeed the right way to characterize things. There are multiple startups, universities, and established companies working in this area, some with overlapping IP claims. It will be interesting to sit back and watch the lawyers get paid large amounts of money to argue about trivialities.
BBoy is offline   Reply With Quote
Old 06-08-2014, 08:51 PM   #19
snetmcom
Senior Member
 
Location: USA

Join Date: Oct 2008
Posts: 152
Default

Quote:
Originally Posted by scbaker View Post
Very interesting. Do you know if they've purchased the IP from $LIFE or if they have any commercialization plans?
I'm curious about this part as well. I wonder if Thermo Fisher dumped any ties with Genia after the Life acquisition?
snetmcom is offline   Reply With Quote
Old 06-08-2014, 09:17 PM   #20
AllSeq
Registered Vendor
 
Location: San Diego, CA

Join Date: Oct 2013
Posts: 138
Default

Quote:
Originally Posted by snetmcom View Post
I'm curious about this part as well. I wonder if Thermo Fisher dumped any ties with Genia after the Life acquisition?
Still haven't heard anything else about the group working on Starlight.

As for Thermo, my assumption is they still own a portion Genia and will make a bit of money on their investment once the acquisition closes.
__________________
AllSeq - The Sequencing Marketplace
[email protected]
www.AllSeq.com
AllSeq is offline   Reply With Quote
Reply

Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off




All times are GMT -8. The time now is 10:49 PM.


Powered by vBulletin® Version 3.8.9
Copyright ©2000 - 2017, vBulletin Solutions, Inc.
Single Sign On provided by vBSSO